{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:15:24Z","timestamp":1772237724035,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.eimc.2009.06.002","type":"journal-article","created":{"date-parts":[[2009,7,22]],"date-time":"2009-07-22T05:09:49Z","timestamp":1248239389000},"page":"412-418","source":"Crossref","is-referenced-by-count":12,"title":["Macr\u00f3lidos y cet\u00f3lidos"],"prefix":"10.1016","volume":"27","author":[{"given":"Nazaret","family":"Cobos-Trigueros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oier","family":"Ateka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Pitart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2009.06.002_bib1","series-title":"Macrolide antibiotics","first-page":"1","article-title":"Discovery of new macrolides","author":"Shiomi","year":"2002"},{"key":"10.1016\/j.eimc.2009.06.002_bib2","unstructured":"Kucers A, Crowe S, Grayson ML, Hoy JF, editors. The Use of Antibiotics. 5.a ed. Oxford: Butterworth Heinemann; 1997."},{"key":"10.1016\/j.eimc.2009.06.002_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00003495-200161040-00003","article-title":"Review of macrolides and ketolides","volume":"61","author":"Zhanel","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.eimc.2009.06.002_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00003495-200161060-00016","article-title":"Telithromycin","volume":"61","author":"Balfour","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.eimc.2009.06.002_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/AAC.45.1.170-175.2001","article-title":"Pharmacokinetics of the new ketolide telithomycin (HMR 3647) administered in ascending single and multiples doses","volume":"45","author":"Namour","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/514619","article-title":"Pharmacodynamics of macrolides, azalides and streptogramins: effect on extracellular pathogens","volume":"27","author":"Carbon","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.eimc.2009.06.002_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF02464953","article-title":"Clinical relevance on intracellular and extracellular concentrations of macrolides","volume":"23","author":"Carbon","year":"1995","journal-title":"Infection"},{"key":"10.1016\/j.eimc.2009.06.002_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/BF01975842","article-title":"High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose","volume":"10","author":"Morris","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2009.06.002_bib9","series-title":"Gu\u00eda de terap\u00e9utica antimicrobiana","year":"2009"},{"key":"10.1016\/j.eimc.2009.06.002_bib10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0149-2918(01)80060-6","article-title":"Pharmacokinetics and tolerability of extended-release clarithromycin","volume":"23","author":"Guay","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.eimc.2009.06.002_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dki241","article-title":"Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models","volume":"56","author":"Girard","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl C","key":"10.1016\/j.eimc.2009.06.002_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/31.suppl_C.11","article-title":"Comparison of macrolides antibiotics","volume":"31","author":"Williams","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib13","series-title":"Current clinical topics in infectious diseases","first-page":"52","article-title":"Azithromycin and clarithromycin","author":"Eisenberg","year":"1994"},{"key":"10.1016\/j.eimc.2009.06.002_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0025-7125(16)30040-2","article-title":"Azithromycin and clarithromycin","volume":"79","author":"Schlossberg","year":"1995","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.eimc.2009.06.002_bib15","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1128\/AAC.37.8.1704","article-title":"Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi","volume":"37","author":"Dever","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jac\/29.2.141","article-title":"In vitro activities of 14, 15 and 16 membered macrolides against gram-positive cocci","volume":"29","author":"Hamilton-Miller","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02098096","article-title":"In vitro activity of azitromycin and tetracycline against 358 clinical isolates of Brucella mellitensis","volume":"11","author":"Landinez","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2009.06.002_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/44.1.1","article-title":"Pneumoncoccal macrolide resistance-myth or reality?","volume":"44","author":"Amsden","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jac\/48.suppl_2.33","article-title":"Activity of the ketolide antibacterial telithromycin against typical community-acquired respiratory pathogens","volume":"48","author":"Felmingham","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/48.suppl_2.1","article-title":"Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site","volume":"48","author":"Douthwaite","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 3","key":"10.1016\/j.eimc.2009.06.002_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1469-0691.2001.0070s3011.x","article-title":"Structure-activity relationships of ketolides vs. macrolides","volume":"7","author":"Douthwaite","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2009.06.002_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.34.3.426","article-title":"Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria","volume":"34","author":"Goldman","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/AAC.45.1.23-29.2001","article-title":"Pharmacodynamics of telithromycin in vitro against respiratory tract pathogens","volume":"45","author":"Odenholt","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl C","key":"10.1016\/j.eimc.2009.06.002_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jac\/31.suppl_C.51","article-title":"Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin","volume":"31","author":"Labro","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/AAC.38.3.528","article-title":"Comparative in vitro exoenzyme-suppresing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa","volume":"38","author":"Mizukane","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/40.2.153","article-title":"Macrolides for the treatment of Pseudomonas aeruginosa infections?","volume":"40","author":"Howe","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/48.suppl_2.9","article-title":"Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin","volume":"48","author":"Leclercq","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/AAC.35.7.1267","article-title":"Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification","volume":"35","author":"Leclercq","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib29","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/AAC.46.6.1629-1633.2002","article-title":"Activity of the ketolide telithromycin is refractory to erm monomethylation of bacterial rRNA","volume":"46","author":"Liu","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib30","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/315853","article-title":"The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: A 6-year population-based assesment","volume":"182","author":"Gay","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2009.06.002_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.eimc.2008.03.003","article-title":"Correlaci\u00f3n entre la prescripci\u00f3n de antibi\u00f3ticos y el descenso de las resistencias a antimicrobianos en el \u00e1rea de salud de Zamora","volume":"27","author":"D\u00edaz","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.06.002_bib32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jac\/dkf128","article-title":"Prevalence of macrolide and tetracycline resistance mechanims in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin","volume":"50","author":"Betriu","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib33","series-title":"New macrolides, azalides, and streptogramins in clinical practice","year":"1995"},{"key":"10.1016\/j.eimc.2009.06.002_bib34","series-title":"Expanding indications for the new macrolides, azalides, and streptogramins","year":"1997"},{"key":"10.1016\/j.eimc.2009.06.002_bib35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/BF01975847","article-title":"Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia","volume":"10","author":"Schonwald","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2009.06.002_bib36","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2009.06.002_bib37","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/archinte.159.21.2576","article-title":"Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia","volume":"159","author":"Stahl","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2009.06.002_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a \u03b2-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Mart\u00ednez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.06.002_bib39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s10096-005-1295-9","article-title":"Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a \u03b2-lactam agent versus a \u03b2-lactam agent alone","volume":"24","author":"Garcia","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2009.06.002_bib40","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"Baddour","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eimc.2009.06.002_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.qco.0000160906.02308.3c","article-title":"Monotherapy versus combination antimicrobial therapy for pneumococcal pneumonia","volume":"18","author":"Waterer","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.eimc.2009.06.002_bib42","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.CCM.0000266755.75844.05","article-title":"Combination antibiotic therapy improves survival in patients with community \u2013acquired pneumonia and shock","volume":"35","author":"Rodriguez","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2009.06.002_bib43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1345\/aph.19174","article-title":"Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals","volume":"34","author":"Dudas","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.eimc.2009.06.002_bib44","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1378\/chest.06-1426","article-title":"Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones","volume":"131","author":"Metersky","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.eimc.2009.06.002_bib45","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1378\/chest.119.5.1420","article-title":"Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states:1993, 1995 and 1997","volume":"119","author":"Houck","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.eimc.2009.06.002_bib46","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.123.5.1503","article-title":"Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database","volume":"123","author":"Brown","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.eimc.2009.06.002_bib47","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1128\/AAC.00006-07","article-title":"Comparison of \u03b2-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib48","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.rmed.2007.04.018","article-title":"Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and readmission","volume":"101","author":"Reyes Calzada","year":"2007","journal-title":"Repir Med"},{"key":"10.1016\/j.eimc.2009.06.002_bib49","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1086\/586749","article-title":"The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy","volume":"46","author":"Charles","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.06.002_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.00054108","article-title":"Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia","volume":"33","author":"Restrepo","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eimc.2009.06.002_bib51","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jac\/dkp088","article-title":"Impact of intravenous \u03b2-lactam\/macrolide versus \u03b2-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia","volume":"63","author":"Tessmer","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007435-199403000-00010","article-title":"Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea","volume":"21","author":"Handsfield","year":"1994","journal-title":"Sexually Transmitted Dis"},{"key":"10.1016\/j.eimc.2009.06.002_bib53","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.43.6.1441","article-title":"Azitromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance","volume":"43","author":"Girgis","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/44.3.411","article-title":"Safety effect on anti-Chlamydia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease","volume":"44","author":"Jackson","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.06.002_bib55","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/01.CIR.0000027820.66786.CF","article-title":"Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflamation and cardiac events in patients with acute coronary syndromes: South thames trial of antibiotics in myocardial infarction and unstable angina (STAMINA)","volume":"106","author":"Stone","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.eimc.2009.06.002_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/13543784.10.2.353","article-title":"Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections","volume":"10","author":"Yassim","year":"2001","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1016\/j.eimc.2009.06.002_bib57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.33.3.397","article-title":"Erythromycin and the gut","volume":"33","author":"Catnach","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.eimc.2009.06.002_bib58","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa040582","article-title":"Oral erythromycin and the risk of sudden death from cardiac causes","volume":"351","author":"Ray","year":"2004","journal-title":"NEJM"},{"key":"10.1016\/j.eimc.2009.06.002_bib59","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJMp078032","article-title":"The FDA and the case of Ketek. 1","volume":"356","author":"Ross","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2009.06.002_bib60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.7326\/0003-4819-144-6-200503210-00121","article-title":"Brief communication: Severe hepatotoxicity of telithromycin: Three case reports and literature review","volume":"144","author":"Clay","year":"2006","journal-title":"Ann Intern Med"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X09003401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X09003401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T12:25:25Z","timestamp":1558441525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X09003401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0213005X09003401"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2009.06.002","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}